Showing results (351-360 of 544) with videos related to
Sort By:
Pageof 55
Journal of Pharmacy Practice|November 28, 2012
Evaluation of discontinuation of atypical antipsychotics prescribed for ICU deliriumKaralea D Jasiak, Ellen A Middleton, James M Camamo, et al.The Science of the Total Environment|March 6, 2020
Multi-scale characterisation of stream nutrient and carbon dynamics in sandy near coastal catchments of south-western AustraliaJen A Middleton, Pauline F Grierson, Neil E Pettit, et al.Frontiers in Immunology|June 7, 2018
SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell ReductionSandra Fernandes, Neetu Srivastava, Raki Sudan, et al.The Journal of Surgical Research|August 13, 2008
Cyclosporine inhibition of angiogenesis involves the transcription factor HESR1Gaurang Shah, Frank A Middleton, Karen L Gentile, et al.Clinical Therapeutics|January 30, 2002
Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infectionsD Allin, I James, J Zachariah, et al.Journal of Medicinal Chemistry|February 3, 2007
Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screeningMichael J Orsini, Mark A Klein, Mary Pat Beavers, et al.Journal of Cell Science|September 1, 1989
The polarization of fibroblasts in early primary cultures is independent of microtubule integrityC A Middleton, A F Brown, R M Brown, et al.Journal of the American Chemical Society|March 12, 2004
Substrate affinities for membrane transport proteins determined by 13C cross-polarization magic-angle spinning nuclear magnetic resonance spectroscopySimon G Patching, Adrian R Brough, Richard B Herbert, et al.Oncotarget|April 7, 2015
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastomaLindi Chen, Raphaël F Rousseau, Steven A Middleton, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Preparation of 3-spirocyclic indolin-2-ones as ligands for the ORL-1 receptorGilles C Bignan, Kathleen Battista, Peter J Connolly, et al.Pageof 55